Wegovy Emerges as Europe’s Top Weight-Loss Drug, Achieving Remarkable Valuation Surge $428bn (£339bn)
The producer of weight reduction drug Wegovy has turned into Europe’s generally important firm, deposing the French extravagance aggregate LVMH. Shares rose after the Danish drug monster, Novo Nordisk, sent off the famous medication in the UK. At the end of exchanging on Monday, the firm had a financial exchange valuation of $428bn (£339bn). The…